Kara E. Geisel

Array ( [id] => 1550053 [patent_doc_number] => 06346523 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Budesonide particles and pharmaceutical compositions containing them' [patent_app_type] => B1 [patent_app_number] => 09/091453 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1430 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346523.pdf [firstpage_image] =>[orig_patent_app_number] => 09091453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260903 [patent_doc_number] => 06204289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Cembranoid inhibitors of nicotinic acetylcholine receptors' [patent_app_type] => 1 [patent_app_number] => 9/092407 [patent_app_country] => US [patent_app_date] => 1998-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1425 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204289.pdf [firstpage_image] =>[orig_patent_app_number] => 092407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087025 [patent_doc_number] => 06025391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Enteric-coated pharmaceutical compositions of mycophenolate' [patent_app_type] => 1 [patent_app_number] => 9/077398 [patent_app_country] => US [patent_app_date] => 1998-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3321 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025391.pdf [firstpage_image] =>[orig_patent_app_number] => 077398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046279 [patent_doc_number] => 05908864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Creatine gel' [patent_app_type] => 1 [patent_app_number] => 9/086934 [patent_app_country] => US [patent_app_date] => 1998-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1695 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908864.pdf [firstpage_image] =>[orig_patent_app_number] => 086934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4020305 [patent_doc_number] => 05907057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Production of D,L-aspartic acid' [patent_app_type] => 1 [patent_app_number] => 9/084626 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3182 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/907/05907057.pdf [firstpage_image] =>[orig_patent_app_number] => 084626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011685 [patent_doc_number] => 05962547 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Reactive radiation- or thermally-initiated cationically-curable epoxide monomers and compositions made from those monomers' [patent_app_type] => 1 [patent_app_number] => 9/078768 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6097 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962547.pdf [firstpage_image] =>[orig_patent_app_number] => 078768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927992 [patent_doc_number] => 05952447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Phenol resin composition and method of producing phenol resin' [patent_app_type] => 1 [patent_app_number] => 9/074404 [patent_app_country] => US [patent_app_date] => 1998-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8373 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952447.pdf [firstpage_image] =>[orig_patent_app_number] => 074404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3997443 [patent_doc_number] => 05922709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Antifungal composition' [patent_app_type] => 1 [patent_app_number] => 9/068116 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3914 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922709.pdf [firstpage_image] =>[orig_patent_app_number] => 068116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156873 [patent_doc_number] => 06103753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Intimal thickening inhibitory agent' [patent_app_type] => 1 [patent_app_number] => 9/068610 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6458 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 265 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103753.pdf [firstpage_image] =>[orig_patent_app_number] => 068610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995023 [patent_doc_number] => 05919830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Stable non-aqueous blends for personal care compositions' [patent_app_type] => 1 [patent_app_number] => 9/070386 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3155 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919830.pdf [firstpage_image] =>[orig_patent_app_number] => 070386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595238 [patent_doc_number] => 06384038 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants' [patent_app_type] => B1 [patent_app_number] => 09/059571 [patent_app_country] => US [patent_app_date] => 1998-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5461 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384038.pdf [firstpage_image] =>[orig_patent_app_number] => 09059571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4206389 [patent_doc_number] => 06077852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Treatment of central nervous system disorders with selective estrogen receptor modulators' [patent_app_type] => 1 [patent_app_number] => 9/057723 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15287 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077852.pdf [firstpage_image] =>[orig_patent_app_number] => 057723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514865 [patent_doc_number] => 06420394 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Topically applied pharmaceutical formulation' [patent_app_type] => B1 [patent_app_number] => 09/057305 [patent_app_country] => US [patent_app_date] => 1998-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1385 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420394.pdf [firstpage_image] =>[orig_patent_app_number] => 09057305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995349 [patent_doc_number] => RE036419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx' [patent_app_type] => 2 [patent_app_number] => 9/049329 [patent_app_country] => US [patent_app_date] => 1998-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5563 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/036/RE036419.pdf [firstpage_image] =>[orig_patent_app_number] => 049329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938606 [patent_doc_number] => 05972993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Composition and method for treating rosacea and sensitive skin with free radical scavengers' [patent_app_type] => 1 [patent_app_number] => 9/045087 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6257 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972993.pdf [firstpage_image] =>[orig_patent_app_number] => 045087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4065400 [patent_doc_number] => 06008192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Hydrophilic binary systems for the administration of lipophilic compounds' [patent_app_type] => 1 [patent_app_number] => 9/041881 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4446 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008192.pdf [firstpage_image] =>[orig_patent_app_number] => 041881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 276721 [patent_doc_number] => RE040839 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2009-07-07 [patent_title] => 'Taxol treatment of cancer' [patent_app_type] => reissue [patent_app_number] => 09/035702 [patent_app_country] => US [patent_app_date] => 1998-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2772 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040839.pdf [firstpage_image] =>[orig_patent_app_number] => 09035702 [rel_patent_id] =>[rel_patent_doc_number] =>)